Henoch-schönlein Purpura (HSP) in a patient on Abemaciclib

por Omarini, Claudia, Molinaro, Eleonora, Barbolini, Monica, Dominici, Massimo, Piacentini, Federico
Publicado 2020

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?

por Toss, Angela, Venturelli, Marta, Peterle, Chiara, Piacentini, Federico, Cascinu, Stefano, Cortesi, Laura
Publicado 2017

Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review

por Maur, Michela, Omarini, Claudia, Piacentini, Federico, Fontana, Annalisa, Pettorelli, Elisa, Cascinu, Stefano
Publicado 2017

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

por Omarini, Claudia, Guaitoli, Giorgia, Pipitone, Stefania, Moscetti, Luca, Cortesi, Laura, Cascinu, Stefano, Piacentini, Federico
Publicado 2018

The Role of Exosomes in Breast Cancer Diagnosis

por Piombino, Claudia, Mastrolia, Ilenia, Omarini, Claudia, Candini, Olivia, Dominici, Massimo, Piacentini, Federico, Toss, Angela
Publicado 2021

Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency

por Bardasi, Camilla, Benatti, Stefania, Luppi, Gabriele, Garajovà, Ingrid, Piacentini, Federico, Dominici, Massimo, Gelsomino, Fabio
Publicado 2022

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review

por Schipilliti, Francesca Matilde, Garajová, Ingrid, Rovesti, Giulia, Balsano, Rita, Piacentini, Federico, Dominici, Massimo, Gelsomino, Fabio
Publicado 2021

Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!

por Omarini, Claudia, Maur, Michela, Luppi, Gabriele, Narni, Franco, Luppi, Mario, Dominici, Massimo, Longo, Giuseppe, Piacentini, Federico
Publicado 2020

Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review

por Canino, Fabio, Piacentini, Federico, Omarini, Claudia, Toss, Angela, Barbolini, Monica, Vici, Patrizia, Dominici, Massimo, Moscetti, Luca
Publicado 2022

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma

por Salati, Massimiliano, Caputo, Francesco, Bocconi, Alessandro, Cerri, Sara, Baldessari, Cinzia, Piacentini, Federico, Dominici, Massimo, Gelsomino, Fabio
Publicado 2022

Personalized Systemic Therapies in Hereditary Cancer Syndromes

por Mastrodomenico, Luciana, Piombino, Claudia, Riccò, Beatrice, Barbieri, Elena, Venturelli, Marta, Piacentini, Federico, Dominici, Massimo, Cortesi, Laura, Toss, Angela
Publicado 2023

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to presc...

por Omarini, Claudia, Piacentini, Federico, Sperduti, Isabella, Barbolini, Monica, Isca, Chrystel, Toss, Angela, Cortesi, Laura, Barbieri, Elena, Dominici, Massimo, Moscetti, Luca
Publicado 2020

Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy

por Omarini, Claudia, Bettelli, Stefania, Manfredini, Samantha, Barbolini, Monica, Isca, Chrystel, Cortesi, Giulia, Maiorana, Antonino, Tazzioli, Giovanni, Dominici, Massimo, Piacentini, Federico
Publicado 2020

T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis

por Omarini, Claudia, Piacentini, Federico, Sperduti, Isabella, Cerma, Krisida, Barbolini, Monica, Canino, Fabio, Nasso, Cecilia, Isca, Christel, Caggia, Federica, Dominici, Massimo, Moscetti, Luca
Publicado 2022

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges

por Cerma, Krisida, Piacentini, Federico, Moscetti, Luca, Barbolini, Monica, Canino, Fabio, Tornincasa, Antonio, Caggia, Federica, Cerri, Sara, Molinaro, Alessia, Dominici, Massimo, Omarini, Claudia
Publicado 2023

Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature

por Isca, Chrystel, Piacentini, Federico, Mastrolia, Ilenia, Masciale, Valentina, Caggia, Federica, Toss, Angela, Piombino, Claudia, Moscetti, Luca, Barbolini, Monica, Maur, Michela, Dominici, Massimo, Omarini, Claudia
Publicado 2021

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

por Omarini, Claudia, Filieri, Maria Elisabetta, Bettelli, Stefania, Manfredini, Samantha, Kaleci, Shaniko, Caprera, Cecilia, Nasso, Cecilia, Barbolini, Monica, Guaitoli, Giorgia, Moscetti, Luca, Maiorana, Antonino, Conte, Pier Franco, Cascinu, Stefano, Piacentini, Federico
Publicado 2018

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications

por Toss, Angela, Piacentini, Federico, Cortesi, Laura, Artuso, Lucia, Bernardis, Isabella, Parenti, Sandra, Tenedini, Elena, Ficarra, Guido, Maiorana, Antonino, Iannone, Anna, Omarini, Claudia, Moscetti, Luca, Cristofanilli, Massimo, Federico, Massimo, Tagliafico, Enrico
Publicado 2018

Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

por Omarini, Claudia, Palumbo, Patrizia, Pecchi, Annarita, Draisci, Stefano, Balduzzi, Sara, Nasso, Cecilia, Barbolini, Monica, Isca, Chrystel, Bocconi, Alessandro, Moscetti, Luca, Galetti, Silvia, Tazzioli, Giovanni, Torricelli, Pietro, Cascinu, Stefano, Piacentini, Federico
Publicado 2019

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer

por Griguolo, Gaia, Dieci, Maria Vittoria, Paré, Laia, Miglietta, Federica, Generali, Daniele Giulio, Frassoldati, Antonio, Cavanna, Luigi, Bisagni, Giancarlo, Piacentini, Federico, Tagliafico, Enrico, Cagossi, Katia, Ficarra, Guido, Prat, Aleix, Conte, Pierfranco, Guarneri, Valentina
Publicado 2021